David J. Schoeneck

Follow

Generating author description...

All published works

Action	Title	Year	Authors
+ PDF Chat	Translation of Innovative Designs Into Phase I Trials	2007	André Rogatko David J. Schoeneck William Jonas Mourad Tighiouart Fadlo R. Khuri Alan L. Porter

Common Coauthors

Coauthor	Papers Together
Alan L. Porter	1
Mourad Tighiouart	1
Fadlo R. Khuri	1
André Rogatko	1
William Jonas	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	Group Up‐and‐Down Designs in Toxicity Studies	2006	Anna Ivanova Nancy Flournoy	1
+	Competing designs for phase I clinical trials: a review	2002	William F. Rosenberger Linda M. Haines	1
+	Theoretical study of the continual reassessment method	2005	John O’Quigley	1
+ PDF Chat	New Paradigm in Dose-Finding Trials: Patient-Specific Dosing and Beyond Phase I	2005	André Rogatko James S. Babb Mourad Tighiouart Fadlo R. Khuri Gary R. Hudes	1
+	Flexible Bayesian methods for cancer phase I clinical trials. Dose escalation with overdose control	2005	Mourad Tighiouart André Rogatko James S. Babb	1
+	Methods for dose finding studies in cancer clinical trials: A review and results of a monte carlo study	1991	John O’Quigley Sylvie Chevret	1
+	Adaptive dose finding for phase I clinical trials of drugs used for chemotherapy of cancer	2002	Douglas M. Potter	1
+	Cancer phase I clinical trials: efficient dose escalation with overdose control	1998	James S. Babb André Rogatko Shelemyahu Zacks	1
+	Statistical Requirements of Phase I Studies	1990	Lutz Edler	1
+	Design and Analysis of Phase I Clinical Trials	1989	Barry E. Storer	1
+	Optimal Bayesian-feasible dose escalation for cancer phase I trials	1998	S. Zacks André Rogatko James S. Babb	1
+	Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer	1990	John O’Quigley Margaret S. Pepe Lloyd D. Fisher	1
+	Phase I trial design: Are new methodologies being put into practice?	1996	Susan Dent E. Eisenhauer	1
+	Patient specific dosing in a cancer phase I clinical trial	2001	James S. Babb André Rogatko	1
+	Trends in the Risks and Benefits to Patients With Cancer Participating in Phase 1 Clinical Trials	2004	Thomas G. Roberts	1
+	Some practical improvements in the continual reassessment method for phase I studies	1995	Steven N. Goodman Marianna Zahurak Steven Piantadosi	1
+	Continual Reassessment Method: A Likelihood Approach	1996	John O’Quigley Larry Z. Shen	1